Final answer:
OSHA does not specifically mandate the evaluation of every marketed drug; this is generally under the jurisdiction of the FDA which ensures post-market drug safety through pharmacovigilance, Phase IV trials, and risk management plans to maintain drug safety and efficacy.
Step-by-step explanation:
The OSHA hazard communication standard does not specifically mandate the evaluation of every marketed drug, as this is primarily the responsibility of the Food and Drug Administration (FDA). Post-market evaluation of drugs is essential for pharmacovigilance, which includes monitoring long-term safety and effects on specific patient subgroups. After approval, there may be further FDA requirements, such as Phase IV trials or risk management plans, which are crucial for ongoing drug safety surveillance.
OSHA's role involves regulating workplace safety, and while it has the authority to adopt regulations to protect workers, this does not typically cover the end-to-end evaluation of pharmaceuticals. The FDA carries out regulation of medicines, requiring rigorous testing before they reach the market, to secure the safety and efficacy of these drugs.
However, there can be drawbacks, as some individuals may suffer from the lack of access to potentially beneficial drugs due to the lengthy FDA approval process.